AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Mirchandani, D Muggia, F
Citation: D. Mirchandani et F. Muggia, Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes, J NAT CANC, 93(18), 2001, pp. 1420-1421

Authors: Demaria, S Volm, MD Shapiro, RL Yee, HT Oratz, R Formenti, SC Muggia, F Symmans, WF
Citation: S. Demaria et al., Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy, CLIN CANC R, 7(10), 2001, pp. 3025-3030

Authors: Hamilton, A Muggia, F
Citation: A. Hamilton et F. Muggia, Estramustine potentiates taxane in prostate and refractory breast cancers, ONCOLOGY-NY, 15(5), 2001, pp. 40-43

Authors: Ferrari, AC Chachoua, A Singh, H Rosenthal, M Taneja, S Bednar, M Mandeli, J Muggia, F
Citation: Ac. Ferrari et al., A phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma, CANCER, 91(11), 2001, pp. 2039-2045

Authors: Symmans, WF Volm, MD Shapiro, RL Perkins, AB Kim, AY Demaria, S Yee, HT McMullen, H Oratz, R Klein, P Formenti, SC Muggia, F
Citation: Wf. Symmans et al., Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: Implications for early prediction of breast cancer response to neoadjuvant treatment, CLIN CANC R, 6(12), 2000, pp. 4610-4617

Authors: Safra, T Muggia, F Jeffers, S Tsao-Wei, DD Groshen, S Lyass, O Henderson, R Berry, G Gabizon, A
Citation: T. Safra et al., Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2), ANN ONCOL, 11(8), 2000, pp. 1029-1033

Authors: Yang, XW Uziely, B Groshen, S Lukas, J Israel, V Russell, C Dunnington, G Formenti, S Muggia, F Press, MF
Citation: Xw. Yang et al., MDR1 gene expression in primary and advanced breast cancer, LAB INV, 79(3), 1999, pp. 271-280
Risultati: 1-7 |